Treatment of ocular hypertension with class I calcium channel bl

Details Treatment of ocular hypertension with class I calcium channel bl Treatment of ocular hypertension with class I calcium channel bl

1987-05-15

1991-01-01

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514913, A61K 31275

Patent

active

049818716

ABSTRACT:
Elevated intraocular pressure in a mammalian eye is lowered by administering to the eye an amount of a Class I calcium channel blocking agent effective to lower the elevated intraocular pressure. A preferred calcium channel blocking agent is verapamil and the preferred mode of administration is topical directly to the eye, e.g., with drops.

REFERENCES:
patent: 4612329 (1986-09-01), Itoh et al.
patent: 4686217 (1987-08-01), Baxter et al.
Chem. Abst., 86:183,208s (1977)-Green et al.
"Elevation of Intraocular Pressure by Calcium Channel Blockers", Jean F. Beatty, M.D., et al, Arch Ophthalmol, vol. 102, Jul. 1984, pp. 1072-1076.
"Anaesthetic Implications of Calcium Channel Blockers", Leonard C. Jenkins et al, Can Anaesth. Soc. J. 1985, 32:4, pp. 436-447.
"The Effect of a Calcium-Channel Blocking Agent on Intraocular Pressure", Monica L. Monica, M.D. et al, American Journal of Ophthalmology, Dec. 1983, p. 814.

Affiliated with

Also associated with

Rating

Treatment of ocular hypertension with class I calcium channel bl does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of ocular hypertension with class I calcium channel bl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of ocular hypertension with class I calcium channel bl will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1996534